ATYR vs. ATAI
ATYR (aTyr Pharma, Inc.) and ATAI (Atai Life Sciences N.V.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, ATYR returned -36.40%/yr vs -26.10%/yr for ATAI. At a 0.26 correlation, their price movements are largely independent.
Performance
ATYR vs. ATAI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ATYR achieves a -39.96% return, which is significantly lower than ATAI's -0.98% return.
ATYR
- 1D
- 4.37%
- 1M
- -4.04%
- YTD
- -39.96%
- 6M
- -35.23%
- 1Y
- -90.99%
- 3Y*
- -40.12%
- 5Y*
- -36.40%
- 10Y*
- -35.88%
ATAI
- 1D
- -0.25%
- 1M
- -6.25%
- YTD
- -0.98%
- 6M
- -5.81%
- 1Y
- 63.31%
- 3Y*
- 37.73%
- 5Y*
- -26.10%
- 10Y*
- —
ATYR vs. ATAI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ATYR aTyr Pharma, Inc. | -39.96% | -78.37% | 156.74% | -35.62% | -70.68% | 59.96% |
ATAI Atai Life Sciences N.V. | -0.98% | 207.52% | -5.67% | -46.99% | -65.14% | -63.67% |
Correlation
The correlation between ATYR and ATAI is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jun 18, 2021 | 0.26 |
Fundamentals
ATYR:
$46.10M
ATAI:
$1.45B
ATYR:
-$0.73
ATAI:
-$2.67
ATYR:
237.16
ATAI:
288.44
ATYR:
0.80
ATAI:
7.29
ATYR:
$190.00K
ATAI:
$3.49M
ATYR:
-$22.33M
ATAI:
$3.49M
ATYR:
-$71.35M
ATAI:
-$663.38M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ATYR vs. ATAI — Risk / Return Rank
ATYR
ATAI
ATYR vs. ATAI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for aTyr Pharma, Inc. (ATYR) and Atai Life Sciences N.V. (ATAI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ATYR | ATAI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.44 | ||
| Sortino ratioReturn per unit of downside risk | -2.40 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.21 | -0.33 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | 1.32 | -2.29 |
| Martin ratioReturn relative to average drawdown | -1.17 | 2.08 | -3.26 |
Loading charts...
Drawdowns
ATYR vs. ATAI - Drawdown Comparison
The maximum ATYR drawdown since its inception was -99.90%, which is greater than ATAI's maximum drawdown of -95.05%. Use the drawdown chart below to compare losses from any high point for ATYR and ATAI.
Loading charts...
Drawdown Indicators
| ATYR | ATAI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.90% | -95.05% | -4.85% |
Max Drawdown (1Y)Largest decline over 1 year | -94.01% | -48.06% | -45.95% |
Max Drawdown (3Y)Largest decline over 3 years | -94.01% | -59.23% | -34.78% |
Max Drawdown (5Y)Largest decline over 5 years | -96.83% | -94.66% | -2.17% |
Max Drawdown (10Y)Largest decline over 10 years | -99.55% | — | — |
Current DrawdownCurrent decline from peak | -99.88% | -80.71% | -19.17% |
Average DrawdownAverage peak-to-trough decline | -93.17% | -80.78% | -12.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 77.49% | 30.56% | +46.93% |
Volatility
ATYR vs. ATAI - Volatility Comparison
aTyr Pharma, Inc. (ATYR) has a higher volatility of 21.70% compared to Atai Life Sciences N.V. (ATAI) at 20.22%. This indicates that ATYR's price experiences larger fluctuations and is considered to be riskier than ATAI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ATYR | ATAI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.70% | 20.22% | +1.48% |
Volatility (6M)Calculated over the trailing 6-month period | 95.12% | 50.35% | +44.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 139.96% | 81.08% | +58.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 89.87% | 83.62% | +6.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 88.44% | 83.63% | +4.81% |
Dividends
ATYR vs. ATAI - Dividend Comparison
Neither ATYR nor ATAI has paid dividends to shareholders.
Financials
ATYR vs. ATAI - Financials Comparison
This section allows you to compare key financial metrics between aTyr Pharma, Inc. and Atai Life Sciences N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ATYR and ATAI have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ATYR has higher volatility (21.70%) compared to ATAI (20.22%). In terms of maximum drawdown, ATYR dropped -99.90% vs ATAI's -95.05%.
ATAI currently has the higher Sharpe Ratio (0.79 vs -0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ATYR and ATAI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer